Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

NCT00086983 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: becatecarin
DRUG: oxaliplatin
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)